← Open Payments lookup

MARY PONDER: Open Payments

NPI 1396288197 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$779 in 52 payments from 15 companies in 2025. Trend: 2023 $971 · 2024 $396 · 2025 $779

Food & beverage: $779
CompanyPaymentsAmount
ABBVIE INC.17$207
Lilly USA, LLC11$157
PFIZER INC.4$67
Amgen Inc.3$52
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$52
Novo Nordisk Inc3$51
AstraZeneca Pharmaceuticals LP2$40
Phathom Pharmaceuticals, Inc.2$24
Eisai Inc.1$21
Abbott Laboratories1$21

Products named: MOUNJARO, UBRELVY, QULIPTA, VRAYLAR, CAPLYTA, NURTEC ODT, FARXIGA, OTEZLA.

Industry payments across MS — which companies pay providers there.